Maximizing Outcomes in Treating Acute Migraine
Trial details
- Registry ID
- NCT03896009
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Maximizing Outcomes in Treating Acute MigraineNCT03896009 | AXSM | Phase 3 | Completed | 2019-12-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |